U.S. Markets closed

iShares Trust - iShares Nasdaq Biotechnology ETF (IBB)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
310.08+0.77 (+0.25%)
At close: 4:00PM EDT

310.08 0.00 (0.00%)
After hours: 4:17PM EDT

People also watch
XBIXLVXLEXLFIWM
Full screen
Previous Close309.31
Open310.92
Bid308.53 x 300
Ask311.88 x 300
Day's Range309.19 - 312.23
52 Week Range246.71 - 329.90
Volume600,336
Avg. Volume1,179,475
Net Assets9.63B
NAV318.95
PE Ratio (TTM)10.78
Yield0.20%
YTD Return20.43%
Beta (3y)1.35
Expense Ratio (net)0.47%
Inception Date2001-02-05
Trade prices are not sourced from all markets
  • Amid corporate career, Merck CEO exonerated man on death row
    CNBC2 days ago

    Amid corporate career, Merck CEO exonerated man on death row

    Frazier said the experience showed him "why there can be no fair and consistent application of the death penalty under the current system."

  • Trade of the Day: Amgen, Inc. (AMGN) Stock Is a Quiet Bull
    InvestorPlace7 days ago

    Trade of the Day: Amgen, Inc. (AMGN) Stock Is a Quiet Bull

    Shares of biotech giant Amgen, Inc. (NASDAQ:AMGN), while higher by roughly 19% for the year, also remains a pain trade for momentum-chasing traders as well as longer-term investors. The broader large-cap biotech space as represented by the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) is also higher by around 18% for the year, which is to say that AMGN stock in terms of performance is trading just about in line with its peers, on average. All else being equal, this would thus also mean that AMGN stock stands a good chance of continuing to trade with this correlation to the IBB ETF.

  • Investopedia8 days ago

    Biotech Breakouts Suggest It Is Time to Buy

    Bullish chart patterns on key biotech names are presenting traders with the best risk/reward setup of 2017.